Brooks Laboratories Ltd Share Price (BROOKS)
as on
| Source : NSE
Brooks Laboratories Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹143.6₹146.88
0.51%
Downside
1.76%
Upside
52 Week's Low
52 Week's High
₹95.55₹198.8633.80%
Downside
37.77%
Upside
| Market Stats | |
| Previous Close | ₹146.16 |
| Open | ₹146.88 |
| Volume | 5,819.00 |
| Upper Circuit | ₹153.46 |
| Lower Circuit | ₹138.85 |
| Day's Low | ₹143.6 |
| Day's High | ₹146.88 |
| 52 Week Low | ₹95.55 |
| 52 Week High | ₹198.86 |
| Returns % | |
| 1 Month Return | -9.5 % |
| 3 Month Return | + 8.35 % |
| 1 Year Return | + 12.76 % |
| 3 Year Return | + 39.2 % |
| 5 Year Return | + 236 % |
Brooks Laboratories Ltd Stock Fundamentals & Key Indicators
Check Brooks Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹430.55 Cr
Return on Equity (ROE)
1.9
PE Ratio (TTM)
-265.75
Return on capital employed (ROCE)
2.72
Industry PE ratio
43.37
Beta (LTM)
0.63
P/B Ratio
3.5
Dividend Yield
0PEG Ratio
-42.38
Quarterly Earnings Growth YOY
-497.51
EPS (TTM)
-7.46
Sector
Pharmaceuticals
Book Value
24.99
Technical Analysis
Bearish
View Technical Analysis
Brooks Laboratories Ltd Stock's Interest Amongst Investors
Brooks Laboratories Ltd Stock Valuation
Track how Brooks Laboratories Ltd P/E has moved over time to understand its valuation trends.
Brooks Laboratories Ltd in the last 5 years
Lowest (-293.64x)
July 22, 2025
Today (-265.75x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (-5.43x)
May 25, 2023
Today’s Price to Earnings Ratio: -265.75x
Brooks Laboratories Ltd Financial Results
Get the annual and quarterly financial summary of Brooks Laboratories Ltd, including revenue, profit, loss and more.
Brooks Laboratories Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Brooks Laboratories Ltd.
Brooks Laboratories Ltd Earnings Results
Brooks Laboratories Ltd’s net profit jumped 497.51% since last year same period to ₹9.58Cr in the Q1 2025-2026. On a quarterly growth basis, Brooks Laboratories Ltd has generated 756.16% jump in its net profits since last 3-months.
Read More about Earnings Results
Brooks Laboratories Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Brooks Laboratories Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 52.62% | 0.00 | |
| Foreign Institutions | 0% | ||
| Mutual Funds | 9.9% | 0.00 | |
| Retail Investors | 37% | 0.15 | |
| Others | 0.48% |
Brooks Laboratories Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Brooks Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 430.55 | 47.2% | 0.55 | -20 | 79 | |
| NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
| NA | 509.12 | 22.09% | 0.00 | NA | NA | |
| NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
| NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Brooks Laboratories Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Brooks Laboratories Ltd.
Brooks Labs Reports Strong Sales Growth in March 2025 - 05 Jun, 2025
Brooks Labs reported consolidated net sales of Rs 23.32 crore for March 2025, a 31.57% increase year-on-year. Despite a quarterly net loss of Rs 1.46 crore, EBITDA rose 107.69% to Rs 2.16 crore. The stock closed at Rs 143.96, with returns of 6.24% over six months and 86.72% over twelve months.
Insights on Brooks Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, -3.96 Cr → 9.58 Cr (in ₹), with an average increase of 82.4% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 36.95% to 37.00% in Jun 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 20.54 Cr → 32.66 Cr (in ₹), with an average increase of 20.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 99.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 10.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 52.62% of holdings in Jun 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, BROOKS stock has moved down by -2.6%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.05% to 0.00% in Jun 2025 quarter
About Brooks Laboratories Ltd
Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.
Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.
Revenue: ₹25.51Cr as on June 2025 (Q1 FY26)
Net Profit: ₹9.58Cr as on June 2025 (Q1 FY26)
Listing date: 05 Sep, 2011
| Organisation | Brooks Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Mutual Funds that own Brooks Laboratories Ltd Stock
Check out the Mutual Funds with significant holdings in Brooks Laboratories Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Quant Business Cycle Fund Direct Growth | 3.53% |
FAQs
What is Brooks Laboratories Ltd share price today?
Brooks Laboratories Ltd share price today stands at ₹144.34, Open: ₹146.88, Previous Close: ₹146.16, High: ₹146.88, Low: ₹143.6, 52 Week High: ₹198.86, 52 Week Low: ₹95.55 as on .
How to buy Brooks Laboratories Ltd shares ?
To buy Brooks Laboratories Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for BROOKS or Brooks Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Brooks Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Brooks Laboratories Ltd?
Today's traded volume of Brooks Laboratories Ltd is 5,819.00. Which means that 5,819.00 shares of Brooks Laboratories Ltd were bought and sold on the stock market during today's trading session.
What is Brooks Laboratories Ltd's market cap today?
Today's market capitalisation of Brooks Laboratories Ltd is ₹430.55 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Brooks Laboratories Ltd?
Brooks Laboratories Ltd’s 52 week high is ₹198.86 and 52 week low is ₹95.55. The current share price of Brooks Laboratories Ltd is ₹144.34, which is -27.42% down from its 52 week high and 51.06% up from its 52 week low.